Topics: Regulation and Legislation

[ULWPQSF id=3563]

Slovakia regulatory snapshot, August 2019

21st August 2019 - Regulatory reports |

Europe
Slovakia
Regulation and Legislation
Regulatory reports

Under Slovak law, CBD is classed as a psychotropic substance and as such it cannot be extracted, stored, or used for manufacture of final products without authorisation under the Narcotics Act

CBD-Intel regulatory news in brief

19th August 2019 - Regulatory briefing |

Asia
California
Europe
Germany
Italy
New Jersey
North America
South Dakota
Spain
Thailand
United Kingdom
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey

Regulatory tracker: current proposed US regulation of CBD (beta)

13th August 2019 - Regulatory trackers |

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory trackers

Welcome to the beta CBD-Intel US Regulatory tracker, updated each month. Within this interactive map gain insight into the proposed bills for all of the US states (excl. Hawaii). This map focuses exclusively on state law; federal, local and enacted laws are not considered, however for more information see our regulatory reports, or use our advanced search to select specific areas of […]

CBD vaping expected to continue growth, say stakeholders

13th August 2019 - Business briefing |

Europe
United Kingdom
Companies
Market Research
Marketing and Retailing
Regulation and Legislation
Technology and Innovation
Business briefing

CBD vaping stakeholders in Europe expect to see the category continue to grow – fuelled by unclear regulations over CBD as a food ingredient combined with a low barrier to entry

New database: Global CBD stakeholders

13th August 2019 - Regulatory trackers |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Lesotho
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Companies
Policy and Politics
Regulation and Legislation
Regulatory trackers

Use our newly updated directory of stakeholders in the global CBD sector to find the most relevant organisations in key markets, with full Web, email, phone and address details. Available exclusively to CBD-Intel subscribers, this once-yearly updated database is a consoldated, user-friendly Excel file. Note that this file is password protected; please enter the password: […]

CBD-Intel bonus midweek regulatory alerts, 8th August 2019

8th August 2019 - Regulatory briefing |

Africa
Canada
Colombia
EU
Europe
Mexico
North America
South America
United States
Zimbabwe
Companies
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and Zimbabwe

Regulatory tracker: current global regulation of CBD August 2019

8th August 2019 - Regulatory trackers |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory trackers

Welcome to the CBD-Intel global regulatory tracker, updated each month. Use the tabs at the top of the map to select a specific regulatory field. Clicking on an individual country will bring up much more detail in the panel below, including links to legislation and CBD-Intel coverage of that market. Updates for August 2019: New […]

CBD-Intel regulatory news in brief

5th August 2019 - Regulatory briefing |

Africa
Arizona
Canada
EU
Europe
Germany
Italy
Luxemburg
Netherlands
North America
North Carolina
Ohio
South Africa
South Carolina
Spain
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa

Chile regulatory snapshot, July 2019

2nd August 2019 - Regulatory reports |

Chile
South America
Regulation and Legislation
Regulatory reports

This report examines the somewhat ambiguous legal position of hemp and CBD products in Chile, where there is no clear legislative regime for CBD, and where isolated CBD is not a scheduled substance

MHRA enforces CBD rules with British store

1st August 2019 - Regulatory briefing |

England
Europe
United Kingdom
Companies
Marketing and Retailing
Regulation and Legislation
Regulatory briefing

A British shop specialising in hemp-related products says it has been told to remove some information from its website by the organisation responsible for regulating medicinal health claims.

Epidyolex takes huge step toward EU licensing

31st July 2019 - Regulatory briefing |

EU
Europe
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.

Italy regulatory snapshot, July 2019

29th July 2019 - Regulatory reports |

Europe
Italy
Regulation and Legislation
Regulatory reports

In our latest regulatory snapshot, we look at the current situation in Italy — where taxes and rules have been changing regularly over recent times

China regulatory snapshot, July 2019

29th July 2019 - Regulatory reports |

Asia
China
Regulation and Legislation
Regulatory reports

CBD-Intel’s report on the regulatory status of CBD in China provides all you need to know about the present legal status of CBD, plus hemp cultivation and much more

CBD-Intel regulatory news in brief

24th July 2019 - Regulatory briefing |

Belgium
Europe
Germany
Italy
North America
North Dakota
United Kingdom
United States
Companies
Policy and Politics
Regulation and Legislation
Regulatory briefing

CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium

CBD-Intel regulatory news in brief

22nd July 2019 - Regulatory briefing |

Asia
California
China
Czech Republic
EU
Europe
France
Germany
Ireland
Italy
Latvia
North America
Ohio
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China

CBD: a fragmented market in an uncertain regulatory landscape

17th July 2019 - Business briefing |

EU
Europe
France
Germany
United Kingdom
Market Research
Marketing and Retailing
Regulation and Legislation
Business briefing

From hummus to suppositories, the UK CBD market is highly fragmented, with over 700 brands available, as CBD-Intel managing director Tim Phillips explains in this presentation given at the Europe CBD Expo in London

CBD-Intel regulatory news in brief

15th July 2019 - Regulatory briefing |

Australasia
Delaware
Europe
Italy
Kentucky
New Zealand
North America
South Dakota
Turkey
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing

CBD-Intel brings you regulatory updates from Italy, France, Turkey, New Zealand, El Salvador, the US states of Delaware and South Dakota and the island territory of Guam

CBD-Intel regulatory news in brief

11th July 2019 - Regulatory briefing |

Argentina
Estonia
Europe
Iowa
Lithuania
North America
South America
Turkey
United States
Companies
Policy and Politics
Regulation and Legislation
Regulatory briefing

An extra helping of regulatory news from CBD-Intel brings you snippets from Argentina, Turkey, Lithuania, Estonia, the US House of Representatives and the state of Iowa

Texas regulatory snapshot, July 2019

10th July 2019 - Regulatory reports |

North America
Texas
United States
Regulation and Legislation
Regulatory reports

The Texas hemp plan, legalising the cultivation, handling and processing of hemp in the state, became law on 10th June – but would-be manufacturers are still having to wait

CBD-Intel regulatory news in brief, 1st-5th July 2019

8th July 2019 - Regulatory briefing |

Belgium
Europe
Germany
Italy
Kansas
Massachusetts
New York
North America
United States
Regulation and Legislation
Regulatory briefing

This week’s round-up of regulatory news in the global CBD market includes updates from US federal authorities, Kansas, Massachusetts, New York City, Belgium, Germany and Italy